Newsroom | 4543 results

SAN DIEGO--(BUSINESS WIRE)--Aspera Biomedicines launches second ADAR1p150 crystallization experiment to the ISS aboard SpaceX CRS-34, advancing oral Rebecsinib for 20+ cancers....

LUGANO, Switzerland--(BUSINESS WIRE)--SERI Lugano Launches International Scientific Outreach Initiative on Light-Based Neuroscience and Pineal Gland Research...

MENLO PARK, Calif.--(BUSINESS WIRE)--Orca Bio announced the appointment of veteran biopharmaceutical executive, Bijan Nejadnik, M.D., as Chief Medical Officer (CMO)....

DURHAM, N.C.--(BUSINESS WIRE)--Target RWE and NoviSci, two leaders in evidence generation, today announced they will rebrand as Pedestal Health and Headwater Science. These two distinct companies will work to build a modern evidence-generation engine for life sciences organizations, navigating the most complex and consequential research challenges. Pedestal Health (formerly Target RWE) is a full-service evidence generation partner for life sciences organizations. The company delivers scientific...

LONDRES, MUNICH et ZURICH--(BUSINESS WIRE)--Le ministère coréen des Sciences et des TIC (MSIT) organisera en juin le Salon mondial de l’emploi postdoctoral InnoCORE 2026, avec des événements prévus à Londres, Munich et Zurich. Cette initiative fait suite au lancement réussi de l’événement à New York, Boston et dans la Silicon Valley en mai 2026. Organisé par le MSIT en collaboration avec le KAIST, le GIST, le DGIST et l’UNIST, ce salon mettra en relation d’excellents chercheurs postdoctoraux du...

LONDON & MÜNCHEN & ZÜRICH--(BUSINESS WIRE)--Das koreanische Ministerium für Wissenschaft und IKT (MSIT) veranstaltet im Juni die InnoCORE Global Postdoctoral Job Fair 2026 mit bevorstehenden Veranstaltungen in London, München und Zürich. Dies folgt auf den erfolgreichen Start der Initiative im Mai 2026 in New York, Boston und im Silicon Valley. Die vom MSIT gemeinsam mit KAIST, GIST, DGIST und UNIST organisierte Jobmesse wird herausragende Postdoktoranden aus aller Welt mit führenden koreanisch...

LONDON & MUNICH & ZURICH--(BUSINESS WIRE)--The Korean government hosts the 2026 InnoCORE Global Postdoctoral Job Fair in London, Munich, and Zurich....

NEW YORK--(BUSINESS WIRE)--AV Laboratories, the science-backed skincare brand redefining the intersection of science, skincare, and longevity, will host an exclusive virtual salon suite on Thursday, May 21, 2026 at 11:00 AM EST for editors, media, and industry insiders. The 30-minute informational session will explore the next frontier of skincare innovation, highlighting the scientific discoveries and advanced research philosophies that inspired AVL’s development and are reshaping the industry...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Tecentriq® (atezolizumab) and Tecentriq Hybreza® (atezolizumab and hyaluronidase-tqjs) as an adjuvant treatment for adult patients with muscle-invasive bladder cancer (MIBC) who have circulating tumor DNA molecular residual disease (ctDNA MRD) after cystectomy, as identified by Natera’s Signatera™ CDx per...

PLANO, Texas--(BUSINESS WIRE)--Secretome Therapeutics, a clinical-stage biotechnology company developing novel cellular and cell-based therapies derived from neonatal cardiac progenitor cells (nCPCs), today announced that members of its management team will participate in three upcoming investor conferences this summer. Secretome is scheduled to attend the following conferences: Jefferies Global Healthcare Conference June 2 – 4, 2026 New York, New York Oppenheimer CNS & Neuro-Muscular Summi...